Nanoparticle platform lit up hidden glioblastoma cells in mice, then destroyed what surgery missed
Researchers at the University of Technology Sydney, Harvard and Henan universities built a double-punch nanoparticle platform that guides surgeons to leftover glioblastoma cells and then destroys them, using the same near-infrared light. In mouse models, every treated animal survived to the sixty-day study endpoint, compared with forty-two days for surgery alone. The peer-reviewed study, published in Science Translational Medicine, has so far only been tested in animals.
Glioblastoma is the most aggressive form of brain cancer, with a five-year survival rate around seven percent, partly because tumor cells spread into healthy brain tissue and surgeons can never remove all of them. Researchers at the University of Technology Sydney, working with Harvard and Henan universities, built a double-punch nanozyme platform to address that problem in two stages. During surgery, the material glows under near-infrared light, helping surgeons see tumor clusters as small as forty-four micrometers, beyond current clinical imaging resolution. After the visible tumor is removed, the same material is reactivated: it converts the tumor's own hydrogen peroxide into oxygen, undoing the low-oxygen shield that normally protects cancer cells, while the light generates heat and reactive molecules that destroy what surgery left behind. In mouse models, every treated animal was alive at sixty days, compared with a survival of forty-two days for mice that had surgery alone, with no detectable neurological or motor side effects. The researchers, whose work was published in the peer-reviewed journal Science Translational Medicine, stress this is still animal research, not a human trial, and that performance still needs to be confirmed at the scale of a human brain.